Ionis Pharmaceuticals, Inc. announced the appointment of Onaiza Cadoret-Manier as chief corporate development and commercial officer reporting to Brett P. Monia, Ph.D., chief executive officer. In this newly created role, Ms. Cadoret-Manier will serve as a member of the company's executive leadership team and be responsible for corporate strategy, commercialization, and operational leadership. Before joining the company, Ms. Cadoret-Manier was the chief commercial officer for Grail Biosciences.